ACTH lowers serum lipids in steroid-treated hyperlipemic patients with kidney disease
Authors:
- 1 August 1996
- journal article
- Published by Elsevier in Kidney International
- Vol. 50 (2) , 538-542
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Growth hormone but not gonadal steroids influence lipoprotein lipase and hepatic lipase activity in hypophysectomized ratsJournal of Endocrinology, 1994
- Low-Dose Simvastatin Is a Well-Tolerated and Efficacious Cholesterol-Lowering Agent in Ciclosporin-Treated Kidney Transplant Recipients: Double-Blind, Randomized, Placebo-Controlled Study in 40 PatientsNephron, 1994
- Direct effects of corticotropin on plasma lipoprotein metabolism in man—Studies in vivo and in vitroMetabolism, 1994
- Evidence for the role of the secretory pattern of growth hormone in the regulation of serum concentrations of cholesterol and apolipoprotein E in ratsJournal of Endocrinology, 1991
- ACTH 1-24 decreases hepatic lipase activities and low density lipoprotein concentrations in healthy menJournal of Internal Medicine, 1991
- Risk factors for accelerated atherosclerosis in renal transplant recipientsThe American Journal of Medicine, 1988
- Lipids and Progressive GlomerulosclerosisAmerican Journal of Nephrology, 1988
- Changes in plasma high density lipoproteins in chronic male alcoholics during and after abuseScandinavian Journal of Clinical and Laboratory Investigation, 1978
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative UltracentrifugeClinical Chemistry, 1972